The merger will increase medication availability and delivery, and enhance the service and quality available to the market, they said. Compounding pharmacies make customized medications for animals when commercial drugs cannot meet their needs.
The new, combined pharmacy will operate as Wedgewood Pharmacy. It will be led by Marcy A. Bliss, Wedgewood’s CEO and president.
The merger will result in more than 500 employees serving over 40,000 clients and hundreds of thousands of animal-owners, they said.
“Combining our two pharmacies will provide more capabilities and enhanced service for all of our customers. Our deep, combined expertise in compounding medications, together with best-practice prescribing tools, will enhance our customers’ experience of doing business with us. We look forward to sharing new preparations, services and tools as they are rolled out. During the process, our integrated pharmacist, customer care, and sales teams will allow us to stay connected with the unique needs of each veterinarian and patient we serve,” Bliss said.
“Our two organizations have a great deal in common, both historically and in serving the unique needs of veterinary medicine today. We both have service- and quality-focused cultures that deliver the best in customer care. That will only get better as we join together to move forward,” Fabian McCarthy, CEO and president of Diamondback Drugs, said.